Prenetics Raises $70M from Tencent Sale, Boosts Liquidity to $171M
Event summary
- Prenetics sold its 35% stake in Insighta to Tencent for $70M, closing on February 13, 2026.
- The deal boosts Prenetics' total adjusted liquidity to $171.1M as of February 15, 2026.
- Proceeds will fuel global expansion of IM8, Prenetics' premium health and longevity brand.
- Prenetics operates with zero debt following the transaction.
- IM8, co-founded with David Beckham, surpassed $100M in annualized recurring revenue in 11 months.
The big picture
Prenetics' sale to Tencent marks the culmination of a strategic shift toward streamlining operations and doubling down on its IM8 brand. The $70M infusion positions the company to compete more aggressively in the premium consumer health space, where scale and brand recognition are increasingly critical. With zero debt and strengthened liquidity, Prenetics joins a growing cohort of health sciences firms leveraging strategic divestments to fund high-growth consumer health initiatives.
What we're watching
- Execution Risk
- Whether Prenetics can sustain IM8's rapid growth trajectory while maintaining profitability.
- Market Expansion
- The pace at which IM8 can scale internationally beyond its current 30-country footprint.
- Strategic Focus
- How the divestment of non-core assets will impact Prenetics' long-term innovation pipeline.
Related topics